title: Macroeconomic and household-level impacts of HIV/AIDS in Botswana.
abstract: OBJECTIVE
  To measure the impact of HIV/AIDS on economic growth and poverty in Botswana and estimate how providing treatment can mitigate its effects.
  
  
  METHODS
  Demographic and financial projections were combined with economic simulation models, including a macroeconomic growth model and a macro-microeconomic computable general equilibrium and microsimulation model.
  
  
  RESULTS
  HIV/AIDS significantly reduces economic growth and increases household poverty. The impact is now severe enough to be affecting the economy as a whole, and threatens to pull some of the uninfected population into poverty. Providing antiretroviral therapy can partly offset this negative effect. Treatment increases health's share of government expenditure only marginally, because it increases economic growth and because withholding treatment raises the cost of other health services.
  
  
  CONCLUSIONS
  Botswana's treatment programme is appropriate from a macroeconomic perspective. Conducting macroeconomic impact assessments is important in countries where prevalence rates are particularly high.
authors.affiliation: Econsult Botswana, Gaborone, Botswana. keith@econsult.co.bw
authors.forename: Keith
authors.initials: K
authors.lastname: Jefferis
authors.forename: Anthony
authors.initials: A
authors.lastname: Kinghorn
authors.forename: Happy
authors.initials: H
authors.lastname: Siphambe
authors.forename: James
authors.initials: J
authors.lastname: Thurlow
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000191:economics; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D001902:Botswana; D003198:Computer Simulation; D017281:Cost of Illness; D003906:Developing Countries; D016527:Drug Costs; D005380:Financing, Government / Q000639:trends; D005544:Forecasting; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics*; D017048:Health Care Costs; D005102:Health Expenditures / Q000639:trends; D006295:Health Resources; D006801:Humans; D018803:Models, Economic; D011203:Poverty
chemical_list: D044966:Anti-Retroviral Agents